BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30114477)

  • 1. NQO1 regulates mitotic progression and response to mitotic stress through modulating SIRT2 activity.
    Kang HJ; Song HY; Ahmed MA; Guo Y; Zhang M; Chen C; Cristofanilli M; Horiuchi D; Vassilopoulos A
    Free Radic Biol Med; 2018 Oct; 126():358-371. PubMed ID: 30114477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A redox-mediated conformational change in NQO1 controls binding to microtubules and α-tubulin acetylation.
    Siegel D; Bersie S; Harris P; Di Francesco A; Armstrong M; Reisdorph N; Bernier M; de Cabo R; Fritz K; Ross D
    Redox Biol; 2021 Feb; 39():101840. PubMed ID: 33360352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT2 knockdown increases basal autophagy and prevents postslippage death by abnormally prolonging the mitotic arrest that is induced by microtubule inhibitors.
    Inoue T; Nakayama Y; Li Y; Matsumori H; Takahashi H; Kojima H; Wanibuchi H; Katoh M; Oshimura M
    FEBS J; 2014 Jun; 281(11):2623-37. PubMed ID: 24712640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deacetylation of the mitotic checkpoint protein BubR1 at lysine 250 by SIRT2 and subsequent effects on BubR1 degradation during the prometaphase/anaphase transition.
    Suematsu T; Li Y; Kojima H; Nakajima K; Oshimura M; Inoue T
    Biochem Biophys Res Commun; 2014 Oct; 453(3):588-94. PubMed ID: 25285631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of P/CAF, as a ubiquitin ligase toward MDM2, suppresses mitotic cell death through p53-p21 activation in HCT116 cells with SIRT2 suppression.
    Li Y; Kokura K; Inoue T
    Biochem Biophys Res Commun; 2019 Jan; 508(1):230-236. PubMed ID: 30482390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis.
    North BJ; Verdin E
    PLoS One; 2007 Aug; 2(8):e784. PubMed ID: 17726514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT2 deacetylates GRASP55 to facilitate post-mitotic Golgi assembly.
    Zhang X; Brachner A; Kukolj E; Slade D; Wang Y
    J Cell Sci; 2019 Nov; 132(21):. PubMed ID: 31604796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress.
    Inoue T; Hiratsuka M; Osaki M; Yamada H; Kishimoto I; Yamaguchi S; Nakano S; Katoh M; Ito H; Oshimura M
    Oncogene; 2007 Feb; 26(7):945-57. PubMed ID: 16909107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox modulation of NQO1.
    Siegel D; Dehn DD; Bokatzian SS; Quinn K; Backos DS; Di Francesco A; Bernier M; Reisdorph N; de Cabo R; Ross D
    PLoS One; 2018; 13(1):e0190717. PubMed ID: 29298345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deacetylation-phosphorylation regulation of SIRT2-SMC1A axis as a mechanism of antimitotic catastrophe in early tumorigenesis.
    Yi F; Zhang Y; Wang Z; Wang Z; Li Z; Zhou T; Xu H; Liu J; Jiang B; Li X; Wang L; Bai N; Guo Q; Guan Y; Feng Y; Mao Z; Fan G; Zhang S; Wang C; Cao L; O'Rourke BP; Wang Y; Wu Y; Wu B; You S; Zhang N; Guan J; Song X; Sun Y; Wei S; Cao L
    Sci Adv; 2021 Feb; 7(9):. PubMed ID: 33627431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer.
    Fagerholm R; Hofstetter B; Tommiska J; Aaltonen K; Vrtel R; Syrjäkoski K; Kallioniemi A; Kilpivaara O; Mannermaa A; Kosma VM; Uusitupa M; Eskelinen M; Kataja V; Aittomäki K; von Smitten K; Heikkilä P; Lukas J; Holli K; Bartkova J; Blomqvist C; Bartek J; Nevanlinna H
    Nat Genet; 2008 Jul; 40(7):844-53. PubMed ID: 18511948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle.
    Dryden SC; Nahhas FA; Nowak JE; Goustin AS; Tainsky MA
    Mol Cell Biol; 2003 May; 23(9):3173-85. PubMed ID: 12697818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors.
    Nioi P; Hayes JD
    Mutat Res; 2004 Nov; 555(1-2):149-71. PubMed ID: 15476858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation.
    Serrano L; Martínez-Redondo P; Marazuela-Duque A; Vazquez BN; Dooley SJ; Voigt P; Beck DB; Kane-Goldsmith N; Tong Q; Rabanal RM; Fondevila D; Muñoz P; Krüger M; Tischfield JA; Vaquero A
    Genes Dev; 2013 Mar; 27(6):639-53. PubMed ID: 23468428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction.
    Ma Q; Kinneer K; Bi Y; Chan JY; Kan YW
    Biochem J; 2004 Jan; 377(Pt 1):205-13. PubMed ID: 14510636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of NAD(P)H:quinone oxidoreductase 1 (NQO1) and genomic gain of the NQO1 locus modulates breast cancer cell sensitivity to quinones.
    Glorieux C; Sandoval JM; Dejeans N; Ameye G; Poirel HA; Verrax J; Calderon PB
    Life Sci; 2016 Jan; 145():57-65. PubMed ID: 26687450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEP-1-SIRT2 inhibits inflammatory response and oxidative stress-induced cell death via expression of antioxidant enzymes in murine macrophages.
    Kim MJ; Kim DW; Park JH; Kim SJ; Lee CH; Yong JI; Ryu EJ; Cho SB; Yeo HJ; Hyeon J; Cho SW; Kim DS; Son O; Park J; Han KH; Cho YS; Eum WS; Choi SY
    Free Radic Biol Med; 2013 Oct; 63():432-45. PubMed ID: 23770196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group IVA Cytosolic Phospholipase A2 Regulates the G2-to-M Transition by Modulating the Activity of Tumor Suppressor SIRT2.
    Movahedi Naini S; Sheridan AM; Force T; Shah JV; Bonventre JV
    Mol Cell Biol; 2015 Nov; 35(21):3768-84. PubMed ID: 26303530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT2 reduces actin polymerization and cell migration through deacetylation and degradation of HSP90.
    Min JS; Kim JC; Kim JA; Kang I; Ahn JK
    Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1230-1238. PubMed ID: 29908203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NAD-dependent deacetylase SIRT2 regulates T cell differentiation involved in tumor immune response.
    Jiang C; Liu J; Guo M; Gao X; Wu X; Bai N; Guo W; Li N; Yi F; Cheng R; Xu H; Zhou T; Jiang B; Sun T; Wei S; Cao L
    Int J Biol Sci; 2020; 16(15):3075-3084. PubMed ID: 33061819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.